Blog

Nelson Moss: CNS metastases are the main challenge in HER2+ breast cancer

Breast Cancer/canceronco.com

Feb 3, 2025, 13:44

Nelson Moss: CNS metastases are the main challenge in HER2+ breast cancer

Nelson Moss, Neurosurgeon at Neurosurgery at Memorial Sloan Kettering, posted on X about recent paper by Emanuela Ferraro et al., titled “Survival Among Patients With ERBB2-Positive Metastatic Breast Cancer and Central Nervous System Disease” published on JAMA Network.

Authors: Emanuela Ferraro, Anne S. Reiner, Rabih Bou Nassif, Umberto Tosi, Samantha Brown, Sabrina Zeller, Chau T. Dang, Andrew D. Seidman, Nelson S. Moss

“CNS metastases=increasingly the main challenge in HER2+ breast cancer. Here we show that fully 55% of patients with such spread suffer CNS-related mortality; even more so in the growing (+longer-surviving) population with CNS-only disease.”

Anne S. Reiner Breast Cancer cancer Emanuela Ferraro Nelson Moss Neurosurgery at Memorial Sloan Kettering OncoDaily Oncology Rabih Bou-Nassif Samantha Brown Umberto Tosi

Oncologist Near Me – Giuseppe Curigliano: A Prominent Specialist in Breast Cancer Clinical Trials and Research

FDA Approves T-DXd for HR+, HER2-Low/Ultralow Breast Cancer Treatment

Oncologist Near Me - Hagop Kantarjian: A Legend in Leukemia Research and Treatment

New Paper Alert: Botensilimab and Balstilimab in Relapsed/Refractory Metastatic Sarcomas

Best of ASCOGI25